WallStreetZenWallStreetZen

NASDAQ: TENX
Tenax Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Tenax Therapeutics earnings were -$64.9M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest TENX earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$17.8M, up 13.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TENX reported annual earnings of -$52.6M, with 198.8% growth.

TENX earnings history

Current Revenue
$0.0
Current Earnings
-$64.9M
Current Profit Margin
0%

TENX Return on Equity

Current Company
-61.5%
Current Industry
-13.6%
Current Market
31.1%
TENX's Return on Equity (-61.5%)... subscribe to Premium to read more.
High Return on Equity Performance

TENX Return on Assets

Current Company
-57.4%
Current Industry
-10.2%
TENX is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when TENX announces earnings.

TENX Return on Capital Employed

Current Company
-57.1%
Current Industry
-6.7%
TENX has gotten more efficient... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

TENX vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
TENX-$64.86M-$64.86MN/A-$1.48
MAIA-$26.85M-$26.85MN/A-$0.62
IBIO-$31.96M-$33.04MN/A-$0.32
GOSS-$113.42M-$125.22MN/A-$0.57
ATHE-$16.68M-$16.76MN/A-$0.96
View Top Biotech Stocks

Tenax Therapeutics Earnings Reports & History FAQ

What were Tenax Therapeutics's earnings last quarter?

On TENX's earnings call on Aug 12, 2026, Tenax Therapeutics (NASDAQ: TENX) reported Q2 2026 earnings per share (EPS) of -$0.35, up 29.63% year over year. Total TENX earnings for the quarter were -$17.80 million. In the same quarter last year, Tenax Therapeutics's earnings per share (EPS) was -$0.27.

If you're new to stock investing, here's how to buy Tenax Therapeutics stock.

Is Tenax Therapeutics profitable or losing money?

As of the last Tenax Therapeutics earnings report, Tenax Therapeutics is currently losing money. Tenax Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$64.86 million, a 106.03% increase year over year.

What was TENX's earnings growth in the past year?

As of Tenax Therapeutics's earnings date in Aug 12, 2026, Tenax Therapeutics's earnings has grown year over year. TENX earnings in the past year totalled -$64.86 million.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.